Detalhe da pesquisa
1.
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.
N Engl J Med
; 389(1): 22-32, 2023 Jul 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37345876
2.
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis.
Hepatology
; 2024 Jan 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38214562
3.
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.
Hepatology
; 2024 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38478755
4.
Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B.
Gut
; 73(4): 659-667, 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37879886
5.
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes.
Clin Infect Dis
; 78(4): 983-990, 2024 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37633256
6.
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis.
J Hepatol
; 80(4): 603-609, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38110003
7.
JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analog suppressed patients with chronic hepatitis B: REEF-2.
J Hepatol
; 2024 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38583491
8.
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
J Hepatol
; 80(1): 20-30, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37734683
9.
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial.
J Hepatol
; 2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38734383
10.
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients.
J Hepatol
; 80(1): 109-123, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37863203
11.
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.
Hepatology
; 78(5): 1654-1673, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37326326
12.
HDV RNA assays: Performance characteristics, clinical utility, and challenges.
Hepatology
; 2023 Aug 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37640384
13.
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods.
Liver Int
; 44(3): 831-837, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38247385
14.
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.
Gut
; 72(7): 1385-1398, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36697207
15.
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro.
Gut
; 72(11): 2123-2137, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36717219
16.
Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.
J Hepatol
; 79(5): 1254-1269, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37377088
17.
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics.
J Hepatol
; 2023 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36931396
18.
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B.
J Hepatol
; 79(1): 50-60, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36893853
19.
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta.
J Hepatol
; 79(3): 657-665, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37120031
20.
Bulevirtide-based treatment strategies for chronic hepatitis delta: A review.
J Viral Hepat
; 30 Suppl 1: 26-32, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36740364